Page last updated: 2024-11-10

cellodextrin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cellodextrin: can be metabolized by some yeast species [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cellooligosaccharide : An oligosaccharide with between two and about 20 D-glucose residues connected by mixed alpha and beta (1->4) glycosidic linkages. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

cellodextrin : A dextrin of varying length (two or more glucose monomers) resulting from cellulolysis, the breakdown of cellulose. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5287993
CHEBI ID3528
CHEBI ID3523
SCHEMBL ID81176
MeSH IDM0188461

Synonyms (27)

Synonym
d-cellotriose
CHEBI:3528
beta-d-glucopyranosyl-(1->4)-beta-d-glucopyranosyl-(1->4)-d-glucopyranose
beta-d-glcp-(1->4)-beta-d-glcp-(1->4)-d-glc
beta-d-glucopyranosyl-(1->4)-beta-d-glucopyranosyl-(1->4)-d-glucose
9061-30-7
cellodextrin
C06219
cellooligosaccharide
C01898
cellotriose ,
d-(+)-cellotriose, >=93%
2-[4,5-dihydroxy-2-(hydroxymethyl)-6-[4,5,6-trihydroxy-2-(hydroxymethyl)tetrahydropyran-3-yl]oxy-tetrahydropyran-3-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
790703C1-D603-49B6-8520-0FD9965B0523
(2s,3r,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,3s,4r,5r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
d-glucose, o-d-glucopyranosyl
d-glucose, o-beta-d-glucopyranosyl
d-glucose, o-beta-d-glucopyranosyl-(1-4)-o-beta-d-glucopyranosyl-(1-4)-
SCHEMBL81176
W-202365
mfcd00069842
CHEBI:3523
GEO-03839
FYGDTMLNYKFZSV-ZWSAEMDYSA-N
(3r,4r,5s,6r)-5-((2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yloxy)tetrahydro-2h-pyran-2-yloxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-2,3,4-triol
o-beta-d-glucopyranosyl-(1->4)-o-beta-d-glucopyranosyl-(1->4)-d-glucose
(beta-d-glc-[1->4])2-d-glc

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
bacterial xenobiotic metaboliteAny bacterial metabolite produced by metabolism of a xenobiotic compound in bacteria.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
glucotrioseAny trisaccharide composed of 3 glucose moieties.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (98)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (3.06)18.7374
1990's19 (19.39)18.2507
2000's12 (12.24)29.6817
2010's52 (53.06)24.3611
2020's12 (12.24)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.93 (24.57)
Research Supply Index4.62 (2.92)
Research Growth Index5.38 (4.65)
Search Engine Demand Index36.32 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (2.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other98 (98.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]